Subarachnoid fibrinolytic treatment for the prevention of cerebral vasospasm.
Findlay
J M
JM
Department of Surgery (Neurosurgery), W.C. Mackenzie Health Sciences Centre, Edmonton, Alberta, Canada.
D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D013345:Subarachnoid Hemorrhage / Q000150:complications; D013346:Subarachnoid Space
D005343:Fibrinolytic Agents